Meihao Medical Group Co., Ltd. (HK:1947) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Meihao Medical Group Co., Ltd. warns of an anticipated net loss between RMB13.2 million to RMB16.2 million for the first half of 2024, attributing the loss to increased staff costs, weakened economic conditions in China affecting their dentistry services, and higher spending on advertising. Despite the expected loss, the company maintains a solid financial position with adequate cash reserves and is focused on business expansion in the upcoming six months. Shareholders and potential investors are cautioned to be prudent when dealing in the company’s shares.
For further insights into HK:1947 stock, check out TipRanks’ Stock Analysis page.